Model for end-stage liver disease (MELD) exception guidelines: results and recommendations from the MELD Exception Study Group and Conference (MESSAGE) for the approval of patients who need liver transplantation with diseases not considered by the standard MELD formula.
Freeman
Richard B
RB
Division of Transplantation, Department of Surgery, Tufts-New England Medical Center, Boston, MA, USA.
Gish
Robert G
RG
Harper
Ann
A
Davis
Gary L
GL
Vierling
John
J
Lieblein
Leslie
L
Klintmalm
Goran
G
Blazek
Jamie
J
Hunter
Robert
R
Punch
Jeffrey
J
D001201:Ascites / Q000601:surgery; D001650:Bile Duct Neoplasms / Q000601:surgery; D003550:Cystic Fibrosis / Q000601:surgery; D006501:Hepatic Encephalopathy / Q000601:surgery; D006801:Humans; D006960:Hyperoxaluria, Primary / Q000601:surgery; D017093:Liver Failure / Q000601:surgery*; D008113:Liver Neoplasms / Q000601:surgery; D016031:Liver Transplantation; D008954:Models, Biological; D017410:Practice Guidelines as Topic; D012720:Severity of Illness Index; D009927:Tissue and Organ Procurement